General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 431: Which of the following tumors has a strong hereditary factor?

A. Retinoblastoma (Correct Answer)
B. Breast carcinoma
C. Bronchogenic carcinoma
D. Pancreatic tumor

Explanation: **Explanation:** **Retinoblastoma** is the correct answer because it is the classic model for hereditary cancer syndromes [1]. It is associated with the **RB1 gene** (a tumor suppressor gene) located on chromosome **13q14** [1]. According to **Knudson’s "Two-Hit" Hypothesis** [2], the hereditary form (40% of cases) involves a germline mutation where the "first hit" is inherited in all body cells [1]. Only one somatic "second hit" is required for tumor development, leading to early-onset, often bilateral, and multifocal tumors [2]. **Analysis of Incorrect Options:** * **Breast Carcinoma:** While hereditary forms exist (e.g., BRCA1/2 mutations) [1], the vast majority (approx. 85-90%) are **sporadic**, occurring due to environmental factors and cumulative genetic damage over time. * **Bronchogenic Carcinoma:** This is primarily driven by **environmental carcinogens**, most notably cigarette smoking. While genetic susceptibility exists, it is not classified as a strongly hereditary tumor. * **Pancreatic Tumor:** Most pancreatic cancers are sporadic [3]. Although associated with syndromes like Peutz-Jeghers or Lynch syndrome in a small percentage of cases, it lacks the definitive hereditary penetrance seen in Retinoblastoma. **High-Yield Clinical Pearls for NEET-PG:** * **RB1 Gene:** The first tumor suppressor gene ever identified [2]. * **Two-Hit Hypothesis:** Essential concept; hereditary cases are "born with one hit," while sporadic cases require two independent somatic mutations [1]. * **Associated Risks:** Patients with hereditary Retinoblastoma have a significantly increased risk of developing **Osteosarcoma** later in life. * **Microscopy:** Look for **Flexner-Wintersteiner rosettes**, which are pathognomonic for Retinoblastoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 298-300. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298.

Question 432: Which of the following is NOT an acute phase reactant?

A. C-reactive protein
B. Ferritin
C. Ceruloplasmin
D. Hemoglobin (Correct Answer)

Explanation: **Explanation:** Acute Phase Reactants (APRs) are proteins whose plasma concentrations increase (positive APRs) or decrease (negative APRs) by at least 25% in response to inflammation, infection, or tissue injury. This process is primarily mediated by cytokines like **IL-6, IL-1, and TNF-α** acting on the liver. **Why Hemoglobin is the Correct Answer:** **Hemoglobin** is an iron-containing protein within red blood cells responsible for oxygen transport [1]. It is not synthesized by the liver in response to inflammatory cytokines and its levels do not fluctuate as a direct "phase" response to acute inflammation. Therefore, it is not classified as an acute phase reactant. **Analysis of Incorrect Options:** * **C-reactive protein (CRP):** The most classic "positive" APR. It acts as an opsonin, fixing complement and facilitating phagocytosis. Its levels rise rapidly (within 6–12 hours) during inflammation. * **Ferritin:** A positive APR that stores iron [2]. During inflammation, ferritin levels rise to sequester iron, depriving invading pathogens of this essential nutrient (a mechanism of "nutritional immunity") [2]. * **Ceruloplasmin:** A positive APR that carries copper and acts as a ferroxidase. It also functions as an antioxidant to scavenge free radicals during the inflammatory response. **NEET-PG High-Yield Pearls:** * **Positive APRs (Mnemonic: "SHF-CCC"):** **S**erum Amyloid A (highest rise), **H**aptoglobin, **F**erritin, **F**ibrinogen, **C**RP, **C**omplement (C3/C4), **C**eruloplasmin. * **Negative APRs (Mnemonic: "TAP"):** **T**ransferrin, **A**lbumin, **P**realbumin (Transthyretin) [1]. Their levels *decrease* during inflammation to conserve amino acids for positive APRs. * **ESR vs. CRP:** ESR is an indirect measure of inflammation (driven largely by Fibrinogen), whereas CRP is a direct biochemical marker. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 657-658. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 658.

Question 433: Which of the following is NOT a transudate?

A. Uremic pleuritis (Correct Answer)
B. Superior vena cava obstruction syndrome
C. Nephrotic syndrome
D. Congestive heart failure

Explanation: **Explanation:** The fundamental distinction between a transudate and an exudate lies in the mechanism of fluid formation. **Transudates** result from imbalances in hydrostatic or osmotic pressure with intact vascular permeability, whereas **exudates** result from increased vascular permeability due to inflammation or malignancy [2]. **1. Why Uremic Pleuritis is the Correct Answer:** Uremic pleuritis occurs in patients with renal failure due to the irritation of pleural surfaces by uremic toxins. This triggers an **inflammatory response**, leading to increased capillary permeability and the leakage of protein-rich fluid and cells [1]. Therefore, it is an **exudate** (specifically often fibrinous). **2. Analysis of Incorrect Options (Transudates):** * **Congestive Heart Failure (CHF):** The most common cause of transudative effusion. It increases systemic/pulmonary venous pressure, leading to increased **hydrostatic pressure** [2]. * **Nephrotic Syndrome:** Characterized by heavy proteinuria, which leads to hypoalbuminemia. This results in decreased **plasma colloid oncotic pressure**, causing fluid to leak into interstitial spaces [3]. * **Superior Vena Cava (SVC) Obstruction:** This causes a localized increase in **hydrostatic pressure** in the upper body and thoracic vessels, forcing protein-poor fluid into the pleural space [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Light’s Criteria:** Used to differentiate exudate from transudate. An exudate meets at least one of: 1. Pleural fluid protein/Serum protein ratio > 0.5 2. Pleural fluid LDH/Serum LDH ratio > 0.6 3. Pleural fluid LDH > 2/3rd the upper limit of normal serum LDH. * **Specific Gravity:** Transudates typically have a specific gravity **< 1.012**, while exudates are **> 1.020**. * **Protein Content:** Transudates have low protein (< 3g/dL); Exudates have high protein (> 3g/dL). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 581-582. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 124. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 126-127. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 124-126.

Question 434: What is the primary action of metalloproteinases?

A. Degradation of collagen (Correct Answer)
B. Polymerization of collagen
C. Oxidation of collagen
D. Stimulation of collagen

Explanation: **Metalloproteinases (MMPs)** are a family of zinc-dependent enzymes essential for the remodeling and degradation of the extracellular matrix (ECM) [1]. Their primary function is the **degradation of collagen** and other ECM components like fibronectin, laminin, and proteoglycans [1]. During tissue repair and wound healing, MMPs are secreted by various cells (macrophages, neutrophils, fibroblasts) as inactive zymogens (pro-MMPs) and are activated by proteases like plasmin. They ensure that the initial "soft" granulation tissue is replaced by a more organized fibrous scar by breaking down excess matrix. **Analysis of Options:** * **Option A (Correct):** MMPs (specifically interstitial collagenases like MMP-1, 2, and 3) cleave the triple helix of fibrillar collagen, making it susceptible to further digestion [1]. * **Option B & D (Incorrect):** Polymerization and stimulation of collagen are functions associated with **TGF-beta** and enzymes like **lysyl oxidase**, which promote collagen cross-linking and synthesis to increase tensile strength. MMPs act in opposition to these processes to prevent excessive fibrosis. * **Option C (Incorrect):** Oxidation is not the mechanism of collagen breakdown; enzymatic hydrolysis by MMPs is the primary pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Zinc Dependency:** MMPs require Zinc ($Zn^{2+}$) as a cofactor for their catalytic activity. * **Regulation:** Their activity is tightly regulated by **TIMPs** (Tissue Inhibitors of Metalloproteinases) [1]. An imbalance between MMPs and TIMPs leads to pathological states like chronic ulcers or excessive scarring (keloids). * **Cancer Metastasis:** Malignant tumors often overexpress MMPs (especially MMP-2 and MMP-9, the gelatinases) to degrade the basement membrane and invade surrounding tissues [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 232-233.

Question 435: What is the usual hematological response to a bacterial infection?

A. Neutropenia
B. Neutrophilia (Correct Answer)
C. Lymphocytosis
D. Eosinophilia

Explanation: **Explanation:** The hallmark hematological response to an acute bacterial infection is **Neutrophilia** [1]. This occurs because neutrophils are the "first responders" of the innate immune system. In response to bacterial invasion, inflammatory cytokines (such as IL-1 and TNF) stimulate the bone marrow to release stored neutrophils into the peripheral blood [3]. If the infection is severe, the marrow also releases immature forms (band cells), a phenomenon known as a **"shift to the left."** **Analysis of Options:** * **Neutrophilia (Correct):** Typical of pyogenic bacterial infections (e.g., *Staphylococcus aureus*, *Streptococcus pneumoniae*) [1], [2]. * **Neutropenia:** This is an abnormal decrease in neutrophils. While it can occur in overwhelming bacterial sepsis (due to excessive consumption) or specific infections like Typhoid fever, it is not the "usual" response [3]. * **Lymphocytosis:** This is the characteristic response to **viral infections** (e.g., Infectious Mononucleosis, Hepatitis) and certain chronic bacterial infections like Tuberculosis or Pertussis [2]. * **Eosinophilia:** This is typically associated with **parasitic infections** (helminths) or **allergic reactions** (Type I Hypersensitivity) [1], [2]. **High-Yield NEET-PG Pearls:** 1. **Leukemoid Reaction:** An extreme elevation of the WBC count (>50,000/mm³) mimicking leukemia, often seen in severe bacterial infections. It is distinguished from CML by a **high LAP (Leukocyte Alkaline Phosphatase) score**. 2. **Toxic Granulations:** Coarse dark granules in the cytoplasm of neutrophils, often seen alongside vacuoles and **Döhle bodies** during severe bacterial infections. 3. **Exception:** Typhoid (Enteric fever) and Brucellosis characteristically present with **leukopenia/neutropenia** rather than neutrophilia [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 592. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 580-581. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 110-111.

Question 436: Dystrophin is absent in which of the following conditions?

A. Duchenne muscular dystrophy (Correct Answer)
B. Becker's muscular dystrophy
C. Myotonic dystrophy
D. Limb-Girdle dystrophy

Explanation: **Explanation:** The correct answer is **Duchenne Muscular Dystrophy (DMD)**. **1. Why Duchenne Muscular Dystrophy is correct:** DMD is an X-linked recessive disorder caused by a **frameshift mutation** (deletions or duplications) in the *DMD* gene, which encodes the protein **Dystrophin** [1]. Dystrophin is a vital structural protein that links the intracellular cytoskeleton (actin) to the extracellular matrix, stabilizing the sarcolemma during muscle contraction. In DMD, the mutation leads to a complete absence of functional dystrophin, resulting in progressive myofiber necrosis and replacement by fibrofatty tissue (pseudohypertrophy) [1], [3]. **2. Why the other options are incorrect:** * **Becker’s Muscular Dystrophy (BMD):** This is also caused by mutations in the *DMD* gene, but these are typically **non-frameshift mutations**. Consequently, dystrophin is produced but is **truncated or qualitatively abnormal** (present in reduced amounts), leading to a milder clinical phenotype compared to DMD [1]. * **Myotonic Dystrophy:** This is an autosomal dominant disorder caused by **CTG trinucleotide repeats** in the *DMPK* gene [2]. It involves defects in RNA-binding proteins, not a primary absence of dystrophin. * **Limb-Girdle Dystrophy:** This is a heterogeneous group of disorders primarily caused by mutations in **sarcoglycan** proteins or other components of the dystrophin-associated glycoprotein complex, but dystrophin itself is usually present. **High-Yield Clinical Pearls for NEET-PG:** * **Gower’s Sign:** Use of hands to "climb up" the legs to stand; characteristic of DMD. * **Pseudohypertrophy:** Calf enlargement due to fat and connective tissue replacement, not muscle hypertrophy. * **Diagnosis:** Gold standard is Genetic Testing; Muscle biopsy shows absent dystrophin staining on immunohistochemistry. * **Common cause of death:** Respiratory failure or Dilated Cardiomyopathy. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1244-1245. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 732-733. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 58-59.

Question 437: Which of the following helps in generating the oxygen burst in neutrophils?

A. Superoxide dismutase
B. Catalase
C. Glutathione peroxidase
D. NADPH oxidase (Correct Answer)

Explanation: **Explanation:** The **Respiratory Burst** (or oxidative burst) is a rapid increase in oxygen consumption by phagocytes (neutrophils and macrophages) during the process of phagocytosis [2]. This process is essential for the intracellular killing of microorganisms. **Why NADPH Oxidase is Correct:** The enzyme **NADPH oxidase** (also known as phagocyte oxidase) is located in the phagosomal membrane [1]. It catalyzes the conversion of molecular oxygen ($O_2$) into the **superoxide anion** ($O_2^{\bullet-}$), using NADPH as an electron donor [1]. This superoxide is the first reactive oxygen species (ROS) produced in the cascade, which is subsequently converted into hydrogen peroxide ($H_2O_2$) and hypochlorite ($HOCl$) to destroy pathogens [2]. **Why the Other Options are Incorrect:** * **A. Superoxide dismutase (SOD):** This enzyme actually *quenches* the burst by converting superoxide into hydrogen peroxide [1]. While part of the pathway, it is considered an antioxidant defense mechanism rather than the generator of the burst [3]. * **B. Catalase:** This is an antioxidant enzyme that breaks down $H_2O_2$ into water and oxygen [1]. It protects cells from oxidative damage but does not generate the burst [3]. * **C. Glutathione peroxidase:** This enzyme reduces $H_2O_2$ to water using reduced glutathione [1]. It serves as a major protective mechanism against free radical injury. **High-Yield Clinical Pearls for NEET-PG:** * **Chronic Granulomatous Disease (CGD):** Caused by a genetic deficiency in **NADPH oxidase**. Patients suffer from recurrent infections with **catalase-positive** organisms (e.g., *S. aureus, Aspergillus, Serratia*) because these organisms neutralize their own $H_2O_2$, leaving the neutrophil with no ROS to kill them. * **Diagnostic Test for CGD:** The **Nitroblue Tetrazolium (NBT) dye test** (fails to turn blue) or the more modern **Dihydrorhodamine (DHR) flow cytometry** test. * **MPO (Myeloperoxidase):** This enzyme converts $H_2O_2$ to $HOCl$ (bleach), which is the most potent bactericidal system in neutrophils [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 59. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 91. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 100-101.

Question 438: A 50-year-old woman, who underwent radical mastectomy and axillary node dissection for breast cancer one year ago, now notices her arm swells by the end of the day. What is the appropriate name for this fluid accumulation?

A. Chylothorax
B. Hydrothorax
C. Lymphedema (Correct Answer)
D. Purulent exudate

Explanation: **Explanation:** The correct answer is **Lymphedema**. **1. Why Lymphedema is correct:** The clinical scenario describes a classic case of **secondary lymphedema**. In patients undergoing radical mastectomy, the surgical removal of axillary lymph nodes and subsequent radiation therapy can disrupt or obstruct the lymphatic drainage pathways of the upper limb [1]. When lymphatic vessels are impaired, protein-rich interstitial fluid cannot be drained effectively, leading to localized accumulation in the subcutaneous tissues. The swelling typically worsens by the end of the day due to the effects of gravity. **2. Why the other options are incorrect:** * **Chylothorax:** This refers specifically to the accumulation of milky, triglyceride-rich lymphatic fluid (chyle) in the **pleural cavity**, usually due to thoracic duct obstruction or trauma [2]. * **Hydrothorax:** This is a non-inflammatory accumulation of serous fluid (transudate) within the **pleural cavity**, commonly seen in systemic conditions like congestive heart failure or cirrhosis. * **Purulent exudate:** This is an inflammatory fluid (pus) rich in neutrophils and cellular debris, typically associated with acute bacterial infections, not mechanical lymphatic obstruction. **3. NEET-PG High-Yield Pearls:** * **Most common cause of lymphedema worldwide:** Filariasis (*Wuchereria bancrofti*) [1]. * **Most common cause of lymphedema in developed countries:** Iatrogenic (surgery or radiation for malignancy) [1]. * **Peau d'orange:** A characteristic skin appearance (resembling orange peel) caused by cutaneous lymphedema where the skin is tethered by sweat glands. * **Stewart-Treves Syndrome:** A rare but high-yield complication where long-standing chronic lymphedema (post-mastectomy) leads to **angiosarcoma**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 124-126. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 125-126.

Question 439: Serum amyloid A protein levels are increased in which of the following conditions?

A. Alzheimer’s disease
B. Ankylosing spondylitis (Correct Answer)
C. Chronic renal failure
D. Malignant hypertension

Explanation: **Explanation:** **Serum Amyloid A (SAA)** is an acute-phase reactant synthesized by the liver under the influence of cytokines like IL-1 and IL-6 [2]. Chronic elevation of SAA is the precursor to **AA (Secondary) Amyloidosis** [1]. 1. **Why Ankylosing Spondylitis is correct:** Ankylosing spondylitis is a chronic systemic inflammatory disorder [3]. Persistent inflammation leads to the continuous release of pro-inflammatory cytokines, which stimulate the liver to produce high levels of SAA [1]. Over time, SAA undergoes proteolysis to form AA amyloid fibrils, which deposit in organs (most commonly the kidneys). Other classic causes include Rheumatoid Arthritis, IBD, and Tuberculosis [1]. 2. **Why other options are incorrect:** * **Alzheimer’s disease:** This is associated with **Aβ (Amyloid Beta)** protein, derived from Amyloid Precursor Protein (APP), not SAA. * **Chronic renal failure:** While long-term dialysis can lead to amyloidosis, the protein involved is **β2-microglobulin (Aβ2M)**, which accumulates because it cannot be filtered by dialysis membranes. * **Malignant hypertension:** This causes fibrinoid necrosis of arterioles and nephrosclerosis, but it is not a primary inflammatory stimulus for SAA production. **High-Yield Clinical Pearls for NEET-PG:** * **AA Amyloidosis:** Associated with chronic inflammation; stains with **Congo Red** (Apple-green birefringence) but is **potassium permanganate sensitive** (loses staining after treatment), unlike AL amyloid. * **AL Amyloidosis:** Most common primary type; associated with Multiple Myeloma (Light chains/Bence-Jones proteins) [4]. * **Transthyretin (ATTR):** Associated with Senile Systemic Amyloidosis (heart) and Familial Amyloid Polyneuropathies [1]. * **Calcitonin (A-Cal):** Associated with Medullary Carcinoma of the Thyroid. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 267-268. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 679-680. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 266-267.

Question 440: A patient with XO chromosomes and short stature is likely to have which of the following conditions?

A. Klinefelter's syndrome
B. Turner's syndrome (Correct Answer)
C. Condy syndrome
D. Condy phenomenon

Explanation: The correct answer is **Turner’s syndrome**. This condition is a classic example of **monosomy** [2], characterized by the presence of a single X chromosome (45, XO karyotype). It is the most common sex chromosome abnormality in females. **Why Turner’s Syndrome is Correct:** The clinical hallmark of Turner’s syndrome is the combination of **short stature** (due to the loss of the *SHOX* gene [1]) and **gonadal dysgenesis** (streak ovaries). The absence of the second X chromosome leads to accelerated oocyte loss, resulting in primary amenorrhea and infertility [3]. Other classic features include a webbed neck (cystic hygroma), cubitus valgus, and cardiovascular anomalies like coarctation of the aorta [1]. **Why Other Options are Incorrect:** * **Klinefelter’s syndrome:** This involves an extra X chromosome in males (typically **47, XXY**). Clinical features include tall stature, testicular atrophy, gynecomastia, and infertility—the opposite of the XO phenotype. * **Condy syndrome / Condy phenomenon:** These are not recognized medical terms or syndromes related to chromosomal pathology. They likely serve as distractors in the question. **High-Yield Clinical Pearls for NEET-PG:** * **Karyotype:** 45, XO is the most common (50%), but mosaics (e.g., 45,X/46,XX) and structural abnormalities (isochromosome Xq) also occur [2]. * **Cardiac Association:** **Bicuspid aortic valve** is the most common cardiac anomaly; **Coarctation of the aorta** is the most specific [1]. * **Renal Association:** **Horseshoe kidney** is frequently seen. * **Biochemical Marker:** Elevated LH and FSH levels due to lack of feedback inhibition from the ovaries (Hypergonadotropic hypogonadism). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 175-177. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 168-169. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 191-192.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free